Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. - PubMed - NCBI
Genet Med. 2017 Jul 27. doi: 10.1038/gim.2017.107. [Epub ahead of print]
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.
Parikh S1,
Goldstein A2,
Karaa A3,
Koenig MK4,
Anselm I5,
Brunel-Guitton C6,
Christodoulou J7,
Cohen BH8,
Dimmock D9,
Enns GM10,
Falk MJ11,
Feigenbaum A12,13,
Frye RE14,
Ganesh J15,
Griesemer D16,
Haas R17,18,
Horvath R19,
Korson M20,
Kruer MC21,
Mancuso M22,
McCormack S23,
Raboisson MJ24,
Reimschisel T25,
Salvarinova R26,
Saneto RP27,
Scaglia F28,
Shoffner J29,
Stacpoole PW30,
Sue CM31,
Tarnopolsky M32,
Van Karnebeek C33,34,
Wolfe LA35,
Cunningham ZZ36,
Rahman S37,
Chinnery PF38.
Abstract
The purpose of this statement is to provide consensus-based recommendations for optimal management and care for patients with primary mitochondrial disease. This statement is intended for physicians who are engaged in the diagnosis and management of these patients. Working group members were appointed by the Mitochondrial Medicine Society. The panel included members with several different areas of expertise. The panel members utilized surveys and the Delphi method to reach consensus. We anticipate that this statement will need to be updated as the field continues to evolve. Consensus-based recommendations are provided for the routine care and management of patients with primary genetic mitochondrial disease.GENETICS in MEDICINE advance online publication, 27 July 2017; doi:10.1038/gim.2017.107.
No hay comentarios:
Publicar un comentario